GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kazia Therapeutics Ltd (ASX:KZA) » Definitions » FFO per Share

Kazia Therapeutics (ASX:KZA) FFO per Share


View and export this data going back to 1994. Start your Free Trial

What is Kazia Therapeutics FFO per Share?

FFO per Share only applies to REITs.


Kazia Therapeutics (ASX:KZA) Business Description

Traded in Other Exchanges
Address
300 Barangaroo Avenue, Level 24, Three International Towers, Sydney, NSW, AUS, 2000
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.